EVALUATION OF NEW RADIOLABELED ANTI-EGFR PEPTIDE MODIFIED BY BIS(SEMICARBAZONE) METAL CHELATOR AS THERANOSTIC STRATEGY IN COLORECTAL AND HEAD AND NECK CANCERS
Hematology, Transfusion and Cell Therapy · 2026-03 · 48 · 106316
DOI: 10.1016/j.htct.2026.106316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-03. Verfasst von Amanda Helena Tejada und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Tejada, A. H., Júnior, G. C. F., Lourenço, G. J., & Lima, C. S. P. (2026). EVALUATION OF NEW RADIOLABELED ANTI-EGFR PEPTIDE MODIFIED BY BIS(SEMICARBAZONE) METAL CHELATOR AS THERANOSTIC STRATEGY IN COLORECTAL AND HEAD AND NECK CANCERS. Hematology, Transfusion and Cell Therapy, 48, 106316. https://doi.org/10.1016/j.htct.2026.106316
Vancouver
Tejada AH, Júnior GCF, Lourenço GJ, Lima CSP. EVALUATION OF NEW RADIOLABELED ANTI-EGFR PEPTIDE MODIFIED BY BIS(SEMICARBAZONE) METAL CHELATOR AS THERANOSTIC STRATEGY IN COLORECTAL AND HEAD AND NECK CANCERS. Hematology, Transfusion and Cell Therapy. 2026;48:106316. doi:10.1016/j.htct.2026.106316
BibTeX
@article{Tejada2026,
author = {Tejada, Amanda Helena and Júnior, Gilberto Carlos Franchi and Lourenço, Gustavo Jacob and Lima, Carmen Silvia Passos},
title = {EVALUATION OF NEW RADIOLABELED ANTI-EGFR PEPTIDE MODIFIED BY BIS(SEMICARBAZONE) METAL CHELATOR AS THERANOSTIC STRATEGY IN COLORECTAL AND HEAD AND NECK CANCERS},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
volume = {48},
pages = {106316},
doi = {10.1016/j.htct.2026.106316}
}
EUVIMED